ISSN: 1871-5206

Journal Home

Journal Guideline

Anti-Cancer Agents in Medicinal Chemistry Q3 Unclaimed

Bentham Science Publishers United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Anti-Cancer Agents in Medicinal Chemistry is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 113. It has a price of 2040 €. It has an SJR impact factor of 0,562 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,562.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q3) Molecular Medicine (Q3) Pharmacology (Q3)

Price

2040 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Anti-Cancer Agents in Medicinal Chemistry

0,562

SJR Impact factor

113

H Index

129

Total Docs (Last Year)

692

Total Docs (3 years)

8429

Total Refs

2052

Total Cites (3 years)

665

Citable Docs (3 years)

2.98

Cites/Doc (2 years)

65.34

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Clinical Pharmacy and Therapeutics Q3
Psychopharmacology Bulletin Q3
Korean Journal of Physiology and Pharmacology Q3
Anti-Cancer Drugs Q3
Behavioural Pharmacology Q3

Compare this journals

Aims and Scope

Best articles by citations

Meet Our Editorial Board Member

The Perplexity of Synergistic Duality: Inter-molecular Mechanisms of Communication in BCR-ABL1

Evaluation of Tissue and Serum Expression Levels of Lactate Dehydrogenase Isoenzymes in Patients with Head and Neck Squamous Cell Carcinoma

An Insight into Purine, Tyrosine and Tryptophan Derived Marine Antineoplastic Alkaloids

Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential

The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells

Integrated Therapeutic Approaches in Head and Neck Cancer: The Importance of Multidisciplinary Team Management

Recent Advances in Hsp90 Inhibitors as Antitumor Agents

Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma

Synthesis of Dihydrazones as Potential Anticancer and DNA Binding Candidates: A Validation by Molecular Docking Studies

Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals

Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review

SHOW MORE ARTICLES

ESM-1: A Novel Tumor Biomaker and its Research Advances

Recent Advances in Multinuclear Complexes as Potential Anticancer and DNA Binding Agents

STAT5 and STAT5 Inhibitors in Hematological Malignancies

Meet Our Editorial Board Member:

Promotion of Optimized Protein Therapy by Bioconjugation as a Polymeric DDS

Dual Antibacterial and Anticancer Activity of 4-Benzoyl-1-dichlorobenzoylthiosemicarbazide Derivatives

Engineered Silver Nanoparticles, A New Nanoweapon Against Cancer

Realizing the Potential of Blueberry as Natural inhibitor of Metastasis and Powerful Apoptosis Inducer: Tapping the Treasure Trove for Effective Regulation of Cell Signaling Pathways.

Changes in Glutathione, Oxidative Stress and Mitochondrial Membrane Potential in Apoptosis Involving the Anticancer Activity of Cantharidin Isolated from Redheaded Blister Beetles, Epicauta hirticornis

Antimetastatic Activities and Mechanisms of Bisdioxopiperazine Compounds

Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy

New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin